Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 12, 2017 9:30 AM - Nov 14, 2017 5:30 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

14th DIA Japan Annual Meeting 2017

[Student Session] Clinical Trial Protocol Development

Session Chair(s)

Maori  Ayabe

Maori Ayabe

Undergraduate Student, Faculty of Pharmaceutical Sciences

Chiba University, Japan

Shouhei  Iimura

Shouhei Iimura

Student

Keio University, Japan

Aya  Okada

Aya Okada

Pharmacovigilance

ASKA Pharmaceutical Co., Ltd., Japan

Miho  Sato

Miho Sato

Undergraduate Student, School of Pharmacy

Showa University, Japan

Clinical trials are essential for evaluating drug safety and efficacy. Moreover, consideration of subjects and choices such as trial designs and evaluation methods are important in conducting them. Therefore, how are ethical and scientific clinical trials designed? This session will provide a lecture on the essence of developing a clinical trial protocol. Subsequently, you will conduct a protocol development by group work and improve understanding. Through active discussion, we would like you to experience the drafting process of a trial plan. In addition, it is desirable to read the following reference because we will deal with antidiabetic drugs as materials for group work: Ministry of Health, Labour and Welfare. “Guideline for Clinical Evaluation of Oral Hypoglycemic Agents”. https://www.pmda.go.jp/files/000208194.pdf, (accessed 2017-05-23).

Speaker(s)

Hideki  Mizusako

Points to Consider for Developing Clinical Study Protocol - Based on the Experience and Actual Cases -

Hideki Mizusako

Daiichi Sankyo Company, Limited, Japan

Clinical Development Department

Yuka  Sakagami

Yuka Sakagami

Yuka Sakagami

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Reviewer, Office of New Drug I

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.